
London-based Causaly builds an AI platform for biomedical research that lets scientists search, connect and synthesize evidence across enormous volumes of life-sciences literature and data.
Instead of reading thousands of papers, researchers can ask questions and surface relationships between drugs, diseases and biological mechanisms. Pharma and biotech teams use it to speed up discovery and decision-making.
It targets the information-overload problem at the heart of modern drug research.